C
Christopher C. Badger
Researcher at Fred Hutchinson Cancer Research Center
Publications - 47
Citations - 4383
Christopher C. Badger is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Monoclonal antibody & Antibody. The author has an hindex of 26, co-authored 47 publications receiving 4306 citations. Previous affiliations of Christopher C. Badger include University of Washington.
Papers
More filters
Journal Article
Chronic graft-versus-host disease and other late complications of bone marrow transplantation.
Keith M. Sullivan,Edward Agura,Claudio Anasetti,Frederick R. Appelbaum,Christopher C. Badger,Scott I. Bearman,K Erickson,Mary E.D. Flowers,J.A. Hansen,Thomas P. Loughran +9 more
Journal ArticleDOI
Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support
Oliver W. Press,Janet F. Eary,Frederick R. Appelbaum,Paul J. Martin,Christopher C. Badger,Wil B. Nelp,Stephan D. Glenn,Greg Butchko,Darrell R. Fisher,Bruce A. Porter,Dana C. Matthews,LD Fisher,Irwin D. Bernstein +12 more
TL;DR: High-dose radioimmunotherapy with 131I-labeled antibodies is associated with a high response rate in patients with B-cell lymphoma in whom antibody biodistribution is favorable.
Journal ArticleDOI
Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published erratum appears in Blood 1989 Aug 15;74(3):1180]
Keith M. Sullivan,Paul L. Weiden,Rainer Storb,Robert P. Witherspoon,A Fefer,LD Fisher,Buckner Cd,Claudio Anasetti,FR Appelbaum,Christopher C. Badger +9 more
TL;DR: It is concluded that acute and chronic GVHD were associated with a durable antileukemic effect and improved survival in patients transplanted in advanced stages of ALL and CML.
Journal ArticleDOI
Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia
Keith M. Sullivan,Paul L. Weiden,R Storb,Robert P. Witherspoon,Alexander Fefer,L D Fisher,C. D. Buckner,Claudio Anasetti,F R Appelbaum,Christopher C. Badger +9 more
TL;DR: In this paper, the influence of graft-versus-host disease (GVHD) on recurrent leukemia and survival after allogeneic marrow transplantation was investigated in 1,202 patients with acute nonlymphocytic leukemia (ANL), acute lymphocyte leukemia (ALL), and chronic myelogenous leukemia (CML) given unmodified marrow grafts from HLA-identical siblings.
Journal ArticleDOI
Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody.
Oliver W. Press,Janet F. Eary,Christopher C. Badger,Paul J. Martin,F R Appelbaum,Ronald Levy,Robert C. Miller,Sherri L. Brown,Wil B. Nelp,Kenneth A. Krohn +9 more
TL;DR: The tolerable toxicity and encouraging efficacy warrant further dose escalation in this phase I trial of anti-CD37 monoclonal antibody MB-1, and all five patients showed preferential localization and retention of MoAb at tumor sites.